Asian Journal of Research and Reports in Endocrinology

Diabetes is a widely prevalent condition and steadily growing as well. In Indian type 2 diabetic patients have a higher amounts of TG and atherogenic lipid sd-LDL. Atherogenic diabetic dyslipidemia is associated with higher residual CV risk and should be treated with a statin as first-line agent. The tendency to develop insulin resistance is a common result of Asian Indians' body composition and dyslipidemia. Diabetic dyslipidemia (DD) is defined by a mild to marked increase in triglyceride-rich lipoproteins, very low-density lipoprotein-cholesterol (VLDL-C) and VLDL-C remnants, and low HDL levels. Along with lifestyle modifications, statins are considered as first-line therapy for diabetic dyslipidemia. Statins have the ability to reduce LDL-C levels by up to 50%. They might improve TG and HDL-C levels further.